logo
Select company
Select metric
-894.31%EBIT Margin
VS
Market
6
Sector
20
Industry
37
History
71
$ 0.81Close
$ 0.68 - $ 2.3 52-Week Range
Ticker Information

Ticker

LGVN

Company Name

LONGEVERON INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

LONGEVERON INC - EBIT Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

LGVN - EBIT % Historical data
DateEarning Before Interest & Taxes (EBIT)EBIT MarginRevenues
6/30/2025$ -18.54M-894.31%$ 2.07M
3/31/2025$ -16.92M-760.63%$ 2.23M
12/31/2024$ -15.97M-667.77%$ 2.39M
9/30/2024$ -17.92M-967.49%$ 1.85M
6/30/2024$ -18.61M-1513.83%$ 1.23M
3/31/2024$ -20.82M-2129.24%$ 978K
12/31/2023$ -21.41M-3020.17%$ 709K
9/30/2023$ -19.84M-2587.09%$ 767K
6/30/2023$ -19.98M-2265.42%$ 882K
3/31/2023$ -19.97M-1765.96%$ 1.13M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • LONGEVERON INC's latest trailing twelve months (TTM) EBIT % stands at -52.48%.
  • Over the past 5 years, LONGEVERON INC's average EBIT % has been -1351.63%.
  • The median EBIT % for LONGEVERON INC during this period was -1374.82%
  • LONGEVERON INC reached its highest EBIT % over the past 5 years at -52.48%.
  • The lowest EBIT % recorded by LONGEVERON INC in the same timeframe -3020.17%

LONGEVERON INC's EBIT % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBIT % Benchmarks
CompanyEBIT %
CYCN : CYCLERION THERAPEUTICS INC -89.51%TRAW : TRAWS PHARMA INC 3028.25%LYRA : LYRA THERAPEUTICS INC -5041.17%ERNA : ERNEXA THERAPEUTICS INC -7890.57%BRTX : BIORESTORATIVE THERAPIES INC -1771.91%APRE : APREA THERAPEUTICS INC -1766.47%XBIO : XENETIC BIOSCIENCES INC -126.03%TXMD : THERAPEUTICSMD INC -20.44%LUCY : INNOVATIVE EYEWEAR INC -390.88%LEXX : LEXARIA BIOSCIENCE CORP -1849.39%

Definition of EBIT Margin

[Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.
EBIT / Revenues
(=) EBIT %
EBIT % for LONGEVERON INC is calculated as follows: EBIT [ $ -2.96M ] / Revenues [ $ 5.64M ]
(=) EBIT % [ -52.48% ]

LGVN - EBIT Margin, Last 5 years

-3020.17%

Minimum

Dec 31, 2023

-52.48%

Maximum

Dec 31, 2019

-1351.63%

Average

-1374.82%

Median

EBIT % Benchmark Analysis

The chart above depicts the distribution of EBIT % for companies in the Total Stock Market. The average EBIT % of the companies is 9.55% with a standard deviation of 23.96%.
The following table provides additional summary stats:
EBIT % in the Market:
filtered constituents3.26K
min-73.16%
max83.08%
average9.55%
median9.01%
std23.96%